←Pulmonary & Critical Care
Asthma exacerbation
📚
🌬️

Asthma exacerbation

Severity, continuous albuterol, steroids, magnesium, the "normal CO₂" trap, and never SABA alone at discharge.

asthmamagnesiumstatus asthmaticusGINA
🗓️ Reviewed 2026-11-18 · ⏱️ 2 min read · 📖 GINA 2025 · NAEPP 2020 focused update · ERS/ATS severe asthma
🧠 Pathophysiology in 60 seconds🔎 Severity💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Albuterol (continuous 10–15 mg/h if severe) + ipratropium first hours + steroids within 1 hour.
  • Severe or not responding → magnesium 2 g IV over 20 min.
  • Danger signs: cannot speak, silent chest, drowsy, normal or rising PaCO₂ (tiring out). → ICU.
  • O₂ target 93–95%.
  • Intubation is high-risk: ketamine, big tube, low rate, long expiration.
  • Discharge: ICS-containing controller (ICS-formoterol MART) — never SABA alone.

🧠 Pathophysiology in 60 seconds

⌄
  • Trigger (virus, allergen, smoke, NSAID, cold air) → bronchospasm + airway edema + mucus plugs.
  • Air trapping → auto-PEEP → high work of breathing and low venous return (hypotension, pulsus).
  • Early: hyperventilation → low PaCO₂. A "normal" PaCO₂ (40) in a struggling asthmatic = fatigue → impending failure.

🔎 Severity

⌄
Feature Moderate Severe Life-threatening
Speech Phrases Words Cannot speak, drowsy
RR <30 >30 Bradypnea
Accessory muscles Some Yes Paradoxical breathing
PEF (% predicted) >50% ≤50% <25% or cannot do
SpO₂ 90–95% <90% Cyanosis
PaCO₂ Low Low/normal Normal → high

Workup: PEF, VBG/ABG if severe, CXR only if pneumothorax/pneumonia suspected or no response. Check potassium (albuterol lowers K) and lactate (albuterol raises it).

💊 Management

⌄
Drug Dose
Albuterol 2.5–5 mg neb q20 min ×3, or continuous 10–15 mg/h; or MDI 4–8 puffs q20 min with spacer
Ipratropium 0.5 mg neb q20 min ×3 (first hours only)
Prednisone 40–50 mg PO daily × 5–7 days (or methylprednisolone 40–80 mg IV if cannot take PO)
Magnesium sulfate 2 g IV over 20 min (severe / poor response)
Epinephrine 0.3–0.5 mg IM if anaphylaxis or near-arrest
Ketamine Bronchodilator; induction agent of choice
  • BiPAP: limited evidence, short trial only in an alert, cooperative patient.
  • Intubation: ketamine 1–2 mg/kg + rocuronium; ETT ≥8.0.
  • Vent: rate 10–12, Vt 6–8 mL/kg, high inspiratory flow (80–100 L/min), I:E ≥1:4. Accept PaCO₂ high (pH >7.15–7.20).
  • Hypotension after intubation → disconnect from vent, press on chest → let air out (auto-PEEP). Rule out pneumothorax.
  • ☐ PEF >60–70% and stable 4–6 h after last bronchodilator
  • ☐ Steroid burst 5–7 days (no taper)
  • ☐ ICS-formoterol as maintenance + reliever (GINA Track 1)
  • ☐ Inhaler technique; written action plan; trigger avoidance
  • ☐ Follow-up 2–7 days; consider biologic referral (frequent severe exacerbations)

⚠️ Pitfalls

⌄
  • Reassured by a "normal" PaCO₂.
  • Sedating an anxious asthmatic outside the ICU.
  • Theophylline / IV aminophylline (little benefit, toxic).
  • Sending home on albuterol alone.

🎓 Board corner

⌄
Stem Answer
Asthma attack, PaCO₂ 44, drowsy Impending respiratory failure → ICU / intubate
No response to 3 nebs + steroids IV magnesium
Asthma + nasal polyps + aspirin reaction AERD (Samter)
Mild intermittent asthma, adult — reliever? As-needed low-dose ICS-formoterol
Intubated asthmatic, BP drops Auto-PEEP → disconnect; check for pneumothorax

📚 References

⌄
  • Global Initiative for Asthma (GINA) 2025 Strategy Report.
  • 2020 NAEPP Focused Update to the Asthma Management Guidelines. JACI. 2020;146:1217.
  • Kew KM, et al. IV magnesium for acute asthma. Cochrane. 2014.
↩︎ Back to 🫁 Pulmonary & Critical Care